Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: Olaparib
Study Purpose: This study was done to learn how well olaparib
works in people with advanced ovarian
cancer who had received chemotherapy
that had worked partly or completely
Protocol Number: D0816L00003
Thank you
Thank you for taking part in the clinical study for the study drug olaparib.
The participants helped researchers learn more about olaparib to help people with ovarian
cancer who had previously received chemotherapy. The participants had completely or partly
responded to chemotherapy treatment.
AstraZeneca sponsored this study and believes it is important to share the results of the study
with you and the public. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you. We hope it helps you understand and feel proud of
your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1